0.0300CAD-25.00%Mkt Cap: 5.46M CADP/E: —Last update: 2026-05-26
Kane Biotech Inc., a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. The company d…
Industry Peers
Biotechnology110.61BUSDP/E 25.8
105.81BDKKP/E 20.4
66.47BUSDP/E 15.5
46.56BEURP/E 30.5
43.89BEURP/E 36.5
39.41BUSDP/E 74.0
32.84BUSD—
32.05BSEKP/E 47.4
Indicators:|
Key Statistics
Company
Market Cap5.46M CAD
Enterprise Value7.77M CAD
Revenue (TTM)427.87K CAD
Gross Profit-640 CAD
Net Income (TTM)-2.72M CAD
Revenue/Share0.0030 CAD
Last Price0.0300 CAD
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees—
CountryCA
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-3.05
EV/Revenue18.15
P/S14.88
P/B-8.75
EPS (TTM)-0.02
EPS (Forward)—
52W Range
0.03000% of range0.0700
52W High0.0700 CAD
52W Low0.0300 CAD
Profitability
Gross Margin-0.15%
Oper. Margin2977.78%
EBITDA Margin0.00%
Profit Margin-636.00%
ROE364.51%
ROA-99.53%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-3.26M CAD
CapEx (TTM)113.13K CAD
FCF Margin-632.31%
FCF Yield-49.59%
Net Debt1.40M CAD
Net Debt/EBITDA-0.55
Balance Sheet
Debt/Equity-3.09
Current Ratio0.68
Quick Ratio0.38
Book Value/Sh-0.0040 CAD
Cash/Share0.0050 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CAD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateMar 13, 2017
Splits
Last Split1:5
Split DateMar 13, 2017
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.181.86M
Float101.94M
Insiders43.35%
Institutions0.00%
Short Interest
Short Ratio0.0d
Short % Out.0.00%
Shares Short12.48K
Short (prev mo.)18.51K
Technical
SMA 500.0358 (-16.2%)
SMA 2000.0388 (-22.7%)
Beta0.25
S&P 52W Chg28.31%
Avg Vol (30d)208.82K
Avg Vol (10d)395.43K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—